Adherence to treatment with β2 long-acting+inhaled steroid from two distinct device and from an unique device in mild-to-moderate asthma: preliminary results of a double-blind telephonic investigation

R. W. Dal Negro, R. Bisato, C. Micheletto, S. Tognella (Bussolengo, Italy)

Source: Annual Congress 2003 - Similarities and differences between β-2 agonists
Session: Similarities and differences between β-2 agonists
Session type: Thematic Poster Session
Number: 1857
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. W. Dal Negro, R. Bisato, C. Micheletto, S. Tognella (Bussolengo, Italy). Adherence to treatment with β2 long-acting+inhaled steroid from two distinct device and from an unique device in mild-to-moderate asthma: preliminary results of a double-blind telephonic investigation. Eur Respir J 2003; 22: Suppl. 45, 1857

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma
Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017
Year: 2018



Effectiveness of a pharmacist-led inhalation technique intervention on asthma and COPD patients: The INspira cluster-randomized controlled trial
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021



A randomized cross-over study of user satisfaction with inhalant devices in asthma patients
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019


Efficacy and safety of sequential three-step empirical therapy for chronic cough: a multi-center clinical study
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial
Source: Eur Respir J, 55 (4) 1902073; 10.1183/13993003.02073-2019
Year: 2020



Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial
Source: Eur Respir J, 54 (5) 1900983; 10.1183/13993003.00983-2019
Year: 2019



Clinical effect on asthma control using a novel digital self-management solution: a physician blinded randomized controlled crossover trial
Source: International Congress 2019 – Medical education to improve practice
Year: 2019




Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Year: 2021



Web-based self-management support after pulmonary rehabilitation of difficult to treat asthma: a randomised controlled trial
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017

Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Budesonide/formoterol adjustable maintenance dosing effectively improves asthma symptom severity: a multicentre Canadian study
Source: Eur Respir J 2003; 22: Suppl. 45, 258s
Year: 2003

Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT)
Source: International Congress 2017 – Many faces of asthma assessment
Year: 2017



Towards optimal patient selection for bronchial thermoplasty treatment in severe asthma: results from the TASMA randomized trial
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019
Year: 2019



Efficacy of an integrated internet community program after pulmonary rehabilitation for COPD patients: a pilot randomized control trial
Source: International Congress 2017 – The importance of physical activity in patients with COPD
Year: 2017




Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial.
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
Source: Eur Respir J, 56 (4) 2000151; 10.1183/13993003.00151-2020
Year: 2020



Late Breaking Abstract - Effect on asthma control using a novel digital self-management system: a physician blinded randomised controlled cross-over pilot trial
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018